RON
GELLER -
INVEST CONT DOCTOR POSTRYC UV
Instituto de Biomedicina de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (8)
2024
-
Cell type-specific adaptation of the SARS-CoV-2 spike
Virus Evolution, Vol. 10, Núm. 1
2023
-
C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein
Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457
-
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Journal of Medical Virology, Vol. 95, Núm. 1
2022
-
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection
Journal of Medical Virology, Vol. 94, Núm. 9, pp. 4216-4223
-
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868
-
The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
PLoS Pathogens, Vol. 18, Núm. 7 July
2021
2020
-
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
Journal of Clinical Virology, Vol. 131